and human colon carcinoma (HT29) cell lines. Malignant and non-malignant cells were cultivated in RPMI medium and incubated with different concentrations of these pyrimidines. Cell viability was evaluated by MTT assay. Apoptotic cells were determined using DAPI (4'-6-diamidino-2-phenylindole) and propidium iodide staining of DNA fragmentation by flow cytometry (sub-G1 peak). 6-Amino-4-(4-chlorophenyl)-2-thioxo-1
通过 Biginelli 型反应合成了 6-amino-4-aryl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitriles 的几种衍
生物,并测试了它们对人乳腺癌 (MCF-7) 的抗增殖活性) 和人结肠癌 (HT29)
细胞系。恶性和非恶性细胞在 RPMI
培养基中培养,并与不同浓度的这些
嘧啶一起培养。通过M
TT测定评估细胞活力。使用 DAPI(4'-6-二脒基-
2-苯基吲哚)和通过流式细胞术(亚 G1 峰)对 DNA 片段化的
碘化丙啶染色确定凋亡细胞。6-
氨基-4-(4-
氯苯基)-2-
硫代-1,2,3,4-四氢
嘧啶-5-甲腈和6-
氨基-4-[4-
二甲氨基)苯基]-2-
硫代-1,与 L929 细胞相比,2,3,4-四氢
嘧啶-5-腈降低 MCF-7 和 HT29 细胞的活力。